title: Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy.
abstract: Photodynamic therapy (PDT) takes advantage of our understanding of the cutaneous response to topically applied porphyrins to selectively destroy malignant or premalignant cells. This type of therapy has been used to treat a variety of cutaneous diseases, including actinic keratoses, basal cell carcinoma, acne, and others. The treatment protocols are not standardized across institutions. We present the Henry Ford Dermatology protocol and early results of our first 150 treatments with PDT.
authors.affiliation: Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA. jrivard1@hfhs.org
authors.forename: Jennifer
authors.initials: J
authors.lastname: Rivard
authors.forename: David
authors.initials: D
authors.lastname: Ozog
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000328:Adult; D000622:Aminolevulinic Acid / Q000627:therapeutic use*; D005260:Female; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D007642:Keratosis / Q000188:drug therapy*; D008297:Male; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000627:therapeutic use*
chemical_list: D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid